BMO Capital Markets analyst M. Ian Somaiya maintains Market Perform rating, but drops price target on Gild Sciences (NASDAQ: GILD) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Gilead Sciences (GILD): 'Acquisition Wanted! - Please Apply Within'February 8, 2017 11:09 AM Options with increasing put volumeFebruary 8, 2017 10:00 AM Gilead Sciences (GILD) Pressured on Market Open, Shares Down 10%February 8, 2017 9:40 AM Active options: GILD AAPL BAC FB DIS JPM TWTR NVDA AMD NFLX AMZN FCX MU GM AKAM GE PGFebruary 8, 2017 9:36 AM Pre-Open Stock Movers 02/08: (MYGN) (COHR) (MCHP) Higher; (GALE) (USNA) (EYES) Lower (more...)February 8, 2017 9:19 AM S&P 500 ekes out gain while banks drag on DowFebruary 8, 2017 7:28 AM Gilead Sciences (GILD) PT Lowered to $75 at RBC CapitalFebruary 8, 2017 7:23 AM Needham & Company Remains Sidelined on Gilead Sciences (GILD) Following 4Q February 8, 2017 6:57 AM Gilead Sciences (GILD) PT Lowered to $83 at JefferiesFebruary 8, 2017 6:40 AM Gilead (GILD) PT Drops to $87 at Baird on 2017 GuidanceFebruary 8, 2017 6:19 AM Piper Jaffray On Gilead (GILD) - It Stinks But If You Hold Your Nose It's Not That BadFebruary 8, 2017 6:12 AM Gilead Sciences (GILD) PT Lowered to $79 at Credit Suisse, Says M&A Is Upside Driver From HereFebruary 8, 2017 5:01 AM Welsl Fargo Lowering PT Range On Gilead (GILD)February 8, 2017 5:00 AM Gilead Sciences (GILD) PT Lowered to $77 at Morgan StanleyFebruary 8, 2017 4:29 AM Citi Downgrades Gilead Sciences (GILD) to NeutralFebruary 8, 2017 4:19 AM Gilead Sciences (GILD) Raises Quarterly Dividend 10.6% to $0.52; 2.8% YieldFebruary 7, 2017 4:03 PM Gilead Sciences (GILD) Tops Q4 EPS by 9c, Offers FY17 GuidanceFebruary 7, 2017 4:03 PM Gilead Sciences Announces 10 Percent Increase in First Quarter 2017 DividendFebruary 7, 2017 4:02 PM Gilead Sciences Announces Fourth Quarter and Full Year 2016 Financial ResultsFebruary 7, 2017 4:01 PM